Clinical Trial Update: A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention [Phase 2]

View source ↗

Summary

A Phase 2 study of RO4905417 in patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Myocardial Infarction

Drugs mentioned

• RO4905417

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED